Relative significance of dopamine receptors, beta adrenoceptors and norepinephrine uptake inhibition in the cardiovascular actions of dopexamine hydrochloride
- 11 August 1988
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (5) , 37C-40C
- https://doi.org/10.1016/s0002-9149(88)80065-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Beneficial Haemodynamic Effects of Intravenous Dopexamine in Patients with Low-Output Heart FailureJournal of Cardiovascular Pharmacology, 1987
- The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and β2-adrenoceptors in the dogJournal of Pharmacy and Pharmacology, 1987
- Acute Hemodynamic and Neuroendocrine Effects of Dopexamine, a New Vasodilator for the Treatment of Heart FailureJournal of Cardiovascular Pharmacology, 1987
- Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failureEuropean Heart Journal, 1986
- The haemodynamic and myocardial effects of dopexamine: a new beta 2‐ adrenoceptor and dopaminergic agonist.British Journal of Clinical Pharmacology, 1986
- Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.Heart, 1985
- The effects of dopexamine on the cardiovascular system of the dogBritish Journal of Pharmacology, 1985
- Dopexamine: a novel agonist at peripheral dopamine receptors and β2‐adrenoceptorsBritish Journal of Pharmacology, 1985
- Effect of Desipramine and Cocaine on Plasma Norepinephrine and Pressor Responses to Adrenergic Stimulation in Pithed RatsThe Journal of Clinical Pharmacology, 1983
- Indirect Sympatliomimetic Activity of Recosen, a Commercial Heart ExtractCardiology, 1966